Fengping Xiao

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Beijing Tide Pharmaceutical Co., Ltd.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fengping Xiao. Retrieved from https://idiyas.com/inventor/fengping-xiao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 11.2

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

6 out of 18

Beijing Tide Pharmaceutical Co., Ltd.

patents

Years Active: 2022-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509479 - P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof (2025-12-30),

2. 12180243 - Receptor inhibitor, pharmaceutical composition comprising same, and use thereof (2024-12-31),

3. 11919918 - P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof (2024-03-05),

4. 11905274 - Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof (2024-02-20),

5. 11453690 - Receptor inhibitor, pharmaceutical composition comprising same, and use thereof (2022-09-27),

6. 11414444 - P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof (2022-08-16),

Title: Innovations of Fengping Xiao in Pharmaceutical Development

Introduction

Fengping Xiao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of receptor inhibitors. With a total of five patents to his name, his work has the potential to impact the treatment of various diseases.

Latest Patents

Fengping Xiao's latest patents include a receptor inhibitor and a pharmaceutical composition comprising the same. This invention discloses a receptor inhibitor of formula (I) and its use in medical applications. Another notable patent is for a P2X3 and/or P2X2/3 receptor antagonist, which also includes a pharmaceutical composition and its application in preparing drugs for preventing or treating diseases mediated by these receptors.

Career Highlights

Fengping Xiao is associated with Beijing Tide Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His expertise in receptor antagonists positions him as a key player in the pharmaceutical industry.

Collaborations

Fengping has collaborated with notable colleagues such as Yanping Zhao and Hongjun Wang. Their combined efforts contribute to the advancement of pharmaceutical research and development.

Conclusion

Fengping Xiao's work in the field of pharmaceuticals, particularly with receptor inhibitors, showcases his innovative spirit and dedication to improving healthcare. His contributions are expected to lead to significant advancements in the treatment of diseases.

Profile summary based on public USPTO records.